DVx Inc. Reports Non-Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings Guidance for the Six Months Ending September 30, 2016; Provides Earnings Guidance for the Full Year Ending March 31, 2017; Provides Dividend Guidance for the Full Year Ending March 31, 2017
August 31, 2016
Share
DVx Inc. reported non-consolidated earnings results for the first quarter ended June 30, 2016. For the quarter, the company reported net sales of JPY 8,515 million, operating income of JPY 377 million, ordinary income of JPY 334 million, profit of JPY 234 million or earnings per share of JPY 20.76 compared to net sales of JPY 7,338 million, operating income of JPY 280 million, ordinary income of JPY 285 million, profit of JPY 520 million or earnings per share of JPY 46.17 per for the same period a year ago. Profit before income tax was JPY 334,555,000 against JPY 762,007,000 a year ago.
For the six months ending September 30, 2016, the company expects net sales of JPY 15,904 million, operating income of JPY 602 million, ordinary income of JPY 602 million, profit of JPY 403 million or earnings per share of JPY 35.80.
For the year ending March 31, 2017, the company expects net sales of JPY 33,200 million, operating income of JPY 1,536 million, ordinary income of JPY 1,536 million, profit of JPY 1,028 million or earnings per share of JPY 91.17.
For the full year ending March 31, 2017, the company expects to declare dividend of JPY 23.00 per share.
DVx Inc. is a Japan-based company mainly engaged in the sale of medical equipment for circulatory system diseases. The Company operates in two business segments. The Arrhythmia segment mainly sells cardiac pacemakers, implantable cardioverter-defibrillators (ICDs), electrode catheters and ablation catheters. The Ischemia segment is engaged in the import and sale of automated contrast medium injectors under the name ACIST, excimer laser angioplasty systems, as well as sale of coronary artery stent products as agency business. The others business is engaged in the sale of neurosurgical products, general surgery related products, gastrointestinal related products, radiation protection supplies, among others.
DVx Inc. Reports Non-Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings Guidance for the Six Months Ending September 30, 2016; Provides Earnings Guidance for the Full Year Ending March 31, 2017; Provides Dividend Guidance for the Full Year Ending March 31, 2017